stem cells Surprise: clear answers and local care

Daily strain often keeps a joint sore

Knees often hurt on stairs, longer walks, or the rise from a chair. A shoulder may ache when you reach, dress, lift, or sleep on it.

Hip soreness often follows sitting and shows up in your first steps. Tell the doctor exactly which motion brings it on.

Small changes can settle mild soreness

When movement makes soreness worse, do less of that motion for several days. Don't quit all movement, because light use may keep the joint from stiffening.

Cold often eases recent swelling; warmth may help a long-standing stiff ache. Check with your doctor before mixing pain medicine with other health needs.

An exam comes before a treatment choice

The doctor starts by asking about the sore spot, then checks movement and swelling. The exam doesn't always settle the cause, so the doctor may consider an X-ray.

QC Kinetix offers regenerative treatments, office procedures that may use prepared fluid from your own blood, bone marrow, or fat, after an exam at its Peoria clinic. Ask which source would be used, where the fluid would go, and what it costs.

The visit also covers your goals, other care, and the likely time involved. You can wait to choose until the doctor explains everything clearly.

The Peoria clinic is the nearest option

The nearest verified QC Kinetix location is in Peoria at 13128 N. 94th Dr., Suite 205, Peoria, AZ 85381. You'll find the office on the Plaza del Rio medical campus, close to Thunderbird Road and Loop 101.

From the Surprise Civic Center area, the trip is roughly nine miles. Call (602) 837-PAIN / (602) 837-7246 if you'd like to ask about a visit.

Sources

1. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023. DOI: 10.1038/s41591-023-02632-w.

2. A 2025 meta-analysis of 73 double-blind placebo-controlled injection trials in 5,895 knee osteoarthritis patients found placebo responder rates above 50 percent at 1, 3 and 6 months, declining by 12 months - which is why any uncontrolled 'our patients improved' claim from a clinic is uninterpretable.

   Previtali D, et al. — Placebo response to intra-articular injections in knee osteoarthritis: magnitude, evolution over time, and influencing factors. A systematic review and meta-analysis with meta-regression. EFORT Open Rev, 2025. DOI: 10.1530/EOR-2025-0022.

3. The OARSI non-surgical management guideline evaluated 60 interventions with GRADE methodology and built its recommendations around core treatments - structured exercise, weight management and self-management education - for every patient with knee osteoarthritis, regardless of what else is added.

   Bannuru RR, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

4. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.